top of page
BPIQ Blog
Feb 22, 20233 min read
Upcoming Pegozafermin NASH Readout!
Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...
Aug 19, 20221 min read
Biopharma Daily Pulse - 08/19/22
$XBI $87.27 | -1.8% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to get...
Aug 19, 20221 min read
Free Biopharma Daily Pulse - 08/19/22
$XBI $87.27 | -1.8% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to get...
Jul 7, 20221 min read
Biopharma Mid Morning Pulse - 07/07/22
(9am MST) $XBI $83.36 | +2.9% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers Top 10 AM...
Jul 7, 20221 min read
Free Biopharma Mid Morning Pulse - 07/07/22
(9am MST) $XBI $83.36 | +2.9% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers Top 10 AM...
Jul 1, 20221 min read
Biopharma Daily Stock Updates - 07/01/22
$XBI $76.54 | +3.06% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +11.1% Novavax Statement on...
Jul 1, 20221 min read
Free Biopharma Daily Stock Updates - 07/01/22
$XBI $76.54 | +3.06% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX +11.1% Novavax Statement on...
Jun 21, 20223 min read
Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 21, 20223 min read
Free Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 10, 20223 min read
Biopharma Pulse - 6/6-6/10 Week in Review
As we begin June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for...
Jun 6, 20224 min read
Biopharma Daily Stock Updates - 06/06/22
$XBI $69.18 | -2.85% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #CYCN +8.6%...
Jun 6, 20224 min read
Free Biopharma Daily Stock Updates - 06/06/22
$XBI $69.18 | -2.85% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #CYCN +8.6%...
Jun 3, 20223 min read
ICPT Reports Mixed PBC Clinical Trials
SUMMARY Ocaliva's approval in PBC required post-approval studies ICPT reported out 1 positive and 1 negative clinical trial result for...
Jun 3, 20222 min read
Biopharma Daily Stock Updates - 06/03/22
$XBI $71.21 | +3.55% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -20% Novavax Statement on...
Jun 3, 20222 min read
Free Biopharma Daily Stock Updates - 06/03/22
$XBI $71.21 | +3.55% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -20% Novavax Statement on...
Feb 1, 20221 min read
Biopharma Pulse - 1/1-1/31 Month in Review
Below we review moves from smid-cap biopharma companies during January 2022. See Table 1 for monthly moves for companies and categories...
Feb 19, 20192 min read
ICPT Ocaliva Phase 3 Readout
An important readout occurred today in the very hot pharmaceutical development area called NASH, a severe fatty liver disease. NASH is...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page